Review
doi: 10.1016/0883-2897(88)90162-6.
Fundamental considerations in the design of fluorine-18 labeled progestins and androgens as imaging agents for receptor-positive tumors of the breast and prostate
Affiliations
- PMID: 3280523
- DOI: 10.1016/0883-2897(88)90162-6
Item in Clipboard
Review
Fundamental considerations in the design of fluorine-18 labeled progestins and androgens as imaging agents for receptor-positive tumors of the breast and prostate
Int J Rad Appl Instrum B.
1988.
No abstract available
Similar articles
-
Synthesis of high affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography.J Med Chem. 1992 May 29;35(11):2113-29. doi: 10.1021/jm00089a024. J Med Chem. 1992. PMID: 1597861
-
Synthesis of C-6 fluoroandrogens: evaluation of ligands for tumor receptor imaging.Steroids. 1995 May;60(5):414-22. doi: 10.1016/0039-128x(95)00009-f. Steroids. 1995. PMID: 7570716
-
Synthesis of 7alpha-(fluoromethyl)dihydrotestosterone and 7alpha-(fluoromethyl)nortestosterone, structurally paired androgens designed to probe the role of sex hormone binding globulin in imaging androgen receptors in prostate tumors by positron emission tomography.J Org Chem. 2007 Jul 20;72(15):5546-54. doi: 10.1021/jo070328b. Epub 2007 Jun 22. J Org Chem. 2007. PMID: 17585812
-
PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins.Q J Nucl Med. 1998 Mar;42(1):8-17. Q J Nucl Med. 1998. PMID: 9646640 Review.
-
Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.Q J Nucl Med Mol Imaging. 2015 Mar;59(1):4-17. Epub 2015 Feb 19. Q J Nucl Med Mol Imaging. 2015. PMID: 25693420 Review.
Cited by
-
[18F]-FDHT PET/CT as a tool for imaging androgen receptor expression in high-grade glioma.Neurooncol Adv. 2021 Jan 29;3(1):vdab019. doi: 10.1093/noajnl/vdab019. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 33738450 Free PMC article.
-
PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging.Cancers (Basel). 2020 Jul 23;12(8):2020. doi: 10.3390/cancers12082020. Cancers (Basel). 2020. PMID: 32718075 Free PMC article. Review.
-
Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.Neoplasia. 2000 Jan-Apr;2(1-2):71-88. doi: 10.1038/sj.neo.7900075. Neoplasia. 2000. PMID: 10933070 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical